Sort by
Refine Your Search
-
on the laboratory’s expertise in conditionally active small molecules, we aim to develop antibacterial compounds that are selectively activated in response to infection. The interested candidate will focus on synthesis
-
project on critical metals from unconventional resources. The project goals are to evaluate the geochemical characteristics of potential feedstocks and develop extraction methods for resources such as rare
-
understanding of the mechanisms of bnAb induction during natural infection. Dr. Williams has been awarded a NIH UM1 grant to develop new vaccine strategies that can induce more protective immune responses in
-
opportunities for scientific and professional development in a successful and sustainable working environment with a collaborative team spirit and world-wide collaborations. Why Duke? At Duke University, you'll
-
environment at Duke University with access to outstanding resources, state-of-the-art core facilities, and opportunities for scientific and professional development. For more information about our research
-
research by visiting https://www.theoliverlab.com/ or searching "Oliver TG" on PubMed. Minimum Requirements: Ph.D. in Cancer Biology, Cell Biology, Molecular Biology, Biochemistry, Genetics, Immunology
-
. Postdoctoral Associate – Translational Microbiome and Critical Care Research The Duke Anesthesiology Microbiome Profiling (AMP) Laboratory (https://anesthesiology.duke.edu/research/serbanescu-lab) under Dr
-
biology, and evolution. Learn more about our interests, motivations and discoveries: https://sites.duke.edu/silverlab/ . Conduct independent research activities under the guidance of a faculty mentor in
-
brain evolution. We employ a multifaceted strategy to bridge developmental neurobiology, RNA biology, and evolution. Learn more about our interests, motivations and discoveries: https://sites.duke.edu
-
elusive, in part due to our limited understanding of the mechanisms of bnAb induction during natural infection. Dr. Williams has been awarded a NIH UM1 grant to develop new vaccine strategies that can